End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
86.3 TWD | +0.70% | +0.12% | +3.98% |
Mar. 07 | UnicoCell Biomed Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 14.4M 442K | Sales 2023 | 24.59M 755K | Capitalization | 4.6B 141M |
---|---|---|---|---|---|
Net income 2022 | -91M -2.79M | Net income 2023 | -84M -2.58M | EV / Sales 2022 | 83.9 x |
Net cash position 2022 | 147M 4.52M | Net cash position 2023 | 403M 12.37M | EV / Sales 2023 | 171 x |
P/E ratio 2022 |
-14.5
x | P/E ratio 2023 |
-53.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 32.43% |
1 day | +0.70% | ||
1 week | +0.12% | ||
Current month | +0.58% | ||
1 month | -1.03% | ||
3 months | -4.64% | ||
6 months | +18.71% | ||
Current year | +3.98% |
Managers | Title | Age | Since |
---|---|---|---|
Chia Chu Tsai
CEO | Chief Executive Officer | - | 18-03-27 |
Pei Lin Chen
DFI | Director of Finance/CFO | - | 18-08-27 |
I Wen Tsai
CHM | Chairman | - | 18-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chia Fang Chang
BRD | Director/Board Member | - | 20-10-11 |
Ming Te Wang
BRD | Director/Board Member | - | 20-10-11 |
Su Lan Lin
BRD | Director/Board Member | - | 20-10-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 86.3 | +0.70% | 10,628 |
24-04-24 | 85.7 | +2.02% | 13,404 |
24-04-23 | 84 | -1.06% | 16,293 |
24-04-22 | 84.9 | -0.12% | 12,379 |
24-04-19 | 85 | -1.39% | 60,868 |
End-of-day quote Taipei Exchange, April 24, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+3.98% | 147M | |
-2.45% | 103B | |
+0.96% | 95.71B | |
+1.66% | 22.02B | |
-17.12% | 20.9B | |
-9.07% | 17.85B | |
-42.83% | 16.21B | |
-14.75% | 15.52B | |
+4.23% | 13.86B | |
+33.46% | 12.04B |
- Stock Market
- Equities
- 6794 Stock